Peptides Explained By John Garrett Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why theyre popular, what the research shows, and the real risks and side effects all in plain language
A comprehensive analysis of clinical and preclinical data reveals that GLP-1 receptor agonists, previously suspected of increasing cancer risk, are generally safe and may even reduce the incidence of certain cancers through improved insulin regulation and immune modulation
Johnson, R
The Rebound Effect Perhaps the most frustrating long-term impact: what happens when treatment ends
up to 5mg up to 7.5mg up to 10mg Tirzepatide drops provide a liquid alternative to the injectable form of this groundbreaking medication for weight management and type 2 diabetes
BPC-157 activates growth factor signaling and nitric oxide pathways to enhance vascular integrity and accelerate healing across muscles, tendons, ligaments, and gut lining